Neuphoria Therapeutics Inc (NEUP)

Dec 09, 2025

Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 09, 2025

Dec 08, 2025

Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees - Yahoo Finance

Dec 08, 2025

Dec 08, 2025

ISS recommends shareholders vote for Neuphoria’s board nominees By Investing.com - Investing.com India

Dec 08, 2025

Dec 08, 2025

Institutional Shareholder Services Recommends Shareholders of Neuphoria to Vote for its Director Nominees - marketscreener.com

Dec 08, 2025

Dec 08, 2025

ISS recommends shareholders vote for Neuphoria’s board nominees - Investing.com

Dec 08, 2025

Dec 08, 2025

Neuphoria Therapeutics (NEUP) Gains ISS Support for Director Nom - GuruFocus

Dec 08, 2025

Dec 08, 2025

Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees - The Manila Times

Dec 08, 2025

Dec 08, 2025

Leading Proxy Advisory Firm ISS Recommends that - GlobeNewswire

Dec 08, 2025

Dec 07, 2025

HC Wainwright Has Lowered Expectations for Neuphoria Therapeutics (NASDAQ:NEUP) Stock Price - Defense World

Dec 07, 2025

Dec 06, 2025

Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail

Dec 06, 2025

Dec 05, 2025

Neuphoria Therapeutics (NEUP) Stock Analysis Report | Financials & Insights - Benzinga

Dec 05, 2025

Dec 05, 2025

HC Wainwright & Co. Maintains Neuphoria Therapeutics (NEUP) Buy Recommendation - Nasdaq

Dec 05, 2025

Dec 05, 2025

NEUP: Analyst Lowers Price Target by 66% but Maintains 'Buy' Rat - GuruFocus

Dec 05, 2025

Dec 05, 2025

Neuphoria continues strategic review amid reduced takeover offer By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Will Neuphoria Therapeutics Inc. stock deliver strong dividend growthIPO Watch & Weekly Watchlist for Hot Stocks - Newser

Dec 05, 2025

Dec 04, 2025

Neuphoria Therapeutics (NEUP) Considers Strategic Alternatives A - GuruFocus

Dec 04, 2025

Dec 04, 2025

Neuphoria continues strategic review amid reduced takeover offer - Investing.com

Dec 04, 2025

Dec 04, 2025

Neuphoria responds to Lynx1's revised indication of interest at a reduced price and premium - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium - The Manila Times

Dec 04, 2025

Dec 03, 2025

Is Neuphoria Therapeutics Inc. stock near bottom after declineEarnings Risk Report & Weekly Top Stock Performers List - Newser

Dec 03, 2025

Dec 02, 2025

Lynx1 Master Sends a Letter to the Shareholders of Neuphoria Therapeutics - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders - Yahoo Finance

Dec 02, 2025

Dec 02, 2025

Lynx1 Master Fund Critiques Neuphoria Therapeutics Inc. Board's Capital-Raising Strategy and Proposes Independent Director Nominees in Proxy Statement - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Neuphoria AFFIRM-1 trial misses primary endpoint, to discontinue SAD program - MSN

Dec 02, 2025

Dec 01, 2025

Neuphoria responds to Lynx1’s proxy contest claims in board dispute By Investing.com - Investing.com Australia

Dec 01, 2025

Dec 01, 2025

Neuphoria Therapeutics (NEUP) Encourages Shareholders to Support Its Nominees - GuruFocus

Dec 01, 2025

Dec 01, 2025

Neuphoria responds to Lynx1’s proxy contest claims in board dispute - Investing.com

Dec 01, 2025

Dec 01, 2025

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - marketscreener.com

Dec 01, 2025

Nov 29, 2025

Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital - MSN

Nov 29, 2025

Nov 28, 2025

Reviewing Neuphoria Therapeutics (NEUP) & The Competition - Defense World

Nov 28, 2025

Nov 27, 2025

What analysts say about Neuphoria Therapeutics Inc stockMACD Histogram Signals & Discover Your Financial Freedom Formula - earlytimes.in

Nov 27, 2025

Nov 27, 2025

Sell Signal: How Neuphoria Therapeutics Inc. stock reacts to global recession fearsSwing Trade & Free AI Powered Buy and Sell Recommendations - moha.gov.vn

Nov 27, 2025

Nov 25, 2025

Lynx1 Capital Management Solicits Proxies from Shareholders of Neuphoria Therapeutics - marketscreener.com

Nov 25, 2025

Nov 24, 2025

Neuphoria urges stockholders to vote for its nominees amid strategic review - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Neuphoria Therapeutics Sends Letter to Stockholders - marketscreener.com

Nov 24, 2025

Nov 24, 2025

Neuphoria Therapeutics (NEUP) Outlines Strategic Review Ahead of Annual Meeting - GuruFocus

Nov 24, 2025

Nov 24, 2025

Making the Most of Varied Backgrounds: Ogunbufunmi’s Bold Move Toward Technology Leadership - Bitget

Nov 24, 2025

Nov 24, 2025

Neuphoria urges stockholders to vote for its nominees amid strategic review By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

Neuphoria Therapeutics Inc. Sends Letter to Stockholders - Yahoo Finance

Nov 24, 2025

Nov 23, 2025

Why Did NEUP Stock Surge 64% Today? - MSN

Nov 23, 2025

Nov 22, 2025

What drives Neuphoria Therapeutics Inc stock priceStop Loss Placement Tips & Small Budget Growth - earlytimes.in

Nov 22, 2025

Nov 21, 2025

Tenax Therapeutics, Inc. (TENX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 21, 2025

Nov 20, 2025

How supply chain issues affect Neuphoria Therapeutics Inc. stock2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Will Neuphoria Therapeutics Inc. stock continue upward momentumMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

What does recent volatility data suggest for Neuphoria Therapeutics Inc.2025 Earnings Impact & Weekly Market Pulse Updates - newser.com

Nov 20, 2025